Commentary by Ilana Bragin, MD, PGY-3
Please also see the clinical vignette presented before last week’s grand rounds.
Last week’s Medical Grand Rounds was given by guest speaker Dr. Sue Quaggin, Associate Professor of Medicine at the University of Toronto, who shared with the …
Commentary by Daniel Fine MD
Faculty Peer Reviewed
Diabetic nephropathy is the most frequent cause of end-stage kidney disease in the United States, Europe and Japan. Large scale randomized controlled trials have shown …
Diseases 2.0 – Bringing you the latest updates on disease pathophysiology and treatment
Commentary By David Goldfarb, M.D. Professor of Medicine, NYU Medical Center, Chief Nephrology Section VA New York Harbor
At the recent meeting …
Commentary by Jatin Roper MD, PGY-3
Medical Grand Rounds today was presented last week by Dr. Shawn Cowper, Assistant Professor of Dermatology and Pathology at Yale University School of Medicine. …
Commentary by Elizabeth Haskins MD, PGY-3
This week’s Grand Rounds was delivered by Dr. Tomas Berl, Chief of the Nephrology Division at the University of Colorado Health Sciences Center in Denver. Dr. Berl’s …
Commentary by Bani Chander MD, PGY-2, and Sergio Obligado MD, Attending Physician, Nephrology
Tumor lysis syndrome (TLS) is characterized by a group of metabolic abnormalities including hyperkalemia, hyperuricemia, and hyperphosphatemia with secondary …
Commentary by Andrew Hardie MD, Body MRI Fellow, NYU Dept of Radiology
The recent discovery of a link between Nephrogenic Systemic Fibrosis (NSF) and the administration of gadolinium contrast for MRI examinations has sent the imaging world …
Commentary by Sarah Berry MD, PGY-3 and Joseph Weisstuch, MD Clinical Assistant Professor of Medicine, Divsion of Nephrology
Case: Mr. K is a 59 year old gentleman with a past medical history of hypertension, non-insulin dependent diabetes mellitus, …